fulvestrant has been researched along with mifepristone in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (17.65) | 18.2507 |
| 2000's | 24 (47.06) | 29.6817 |
| 2010's | 16 (31.37) | 24.3611 |
| 2020's | 2 (3.92) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, DA; Barbieri, LR; Berrodin, TJ; Bigelis, R; Chang, LP; Luckman, SW; McDonald, LA; Roll, DM; Singh, MP; Yudt, MR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adler, S; Dibbs, KI; Fuchs, AR; Koide, SS; Li, XJ; Sadovsky, Y | 1 |
| Manning, DL; Nicholson, RI | 1 |
| Bonney, RC; Franks, S; Watson, H | 1 |
| Bardin, CW; Dao, B; Koide, SS; Marshall, A; Vanage, G | 1 |
| Koide, SS; Li, XJ; Yu, H | 1 |
| Rao, AJ; Shanker, YG | 1 |
| Chadwick, CC; Hermsmeyer, K; Minshall, RD; Miyagawa, K; Novy, MJ | 1 |
| Chen, GT; Getsios, S; MacCalman, CD | 1 |
| Gui, Y; Lessey, BA; Yuan, L; Zhang, J | 1 |
| Chiappetta, C; Hyder, SM; Stancel, GM | 1 |
| Diamandis, EP; Grass, L; Jenkins, DJ; Magklara, A; Rosenberg Zand, RS | 1 |
| Boettger-Tong, H; Chiappetta, C; Huang, JC; Hyder, SM; Mäkelä, S; Nawaz, Z; Stancel, GM | 1 |
| Haslam, SZ; Hofseth, LJ; Raafat, AM | 1 |
| Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
| Alban, P; Dinda, S; Hurd, C; Khattree, N; Moudgil, VK | 1 |
| Abrahamson, DR; Das, SK; Dey, SK; Ma, W; Matsumoto, H; Robert, B; Tan, J | 1 |
| Lee, TJ; Shah, GV; Sun, YP | 1 |
| Dong, YL; Gangula, PR; Kondapaka, SB; Vegiraju, S; Wimalawansa, SJ; Yallampalli, C | 1 |
| Chauhan, M; Dong, YL; Vegiraju, S; Yallampalli, C | 1 |
| Diamandis, EP; Grass, L; Luo, LY | 1 |
| Barrett, JT; Delk, JN; Gaddy, VT; Kallab, AM; Porter, AG; Schoenlein, PV | 1 |
| Choi, KC; Hong, EJ; Jeung, EB; Jung, YW | 1 |
| Gu, G; Härkönen, PL; Hentunen, TA; Nars, M; Väänänen, HK | 1 |
| Kwan, CY; Kwan, TK; Wu, YJ; Younglai, EV | 1 |
| Lee, HY; Sherwood, OD | 1 |
| Hyder, SM; Liang, Y; Nawaz, Z; Wu, J | 1 |
| Gupta, A; Mao, Q; Unadkat, JD; Vethanayagam, RR; Wang, H; Zhang, Y; Zhou, L | 1 |
| Jorgenson, RL; Lesmeister, MJ; Misfeldt, ML; Young, SL | 1 |
| Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G; Smith, CL | 1 |
| Guo, SW; Wu, Y | 1 |
| Croxatto, HB; Garfield, R; Ortiz, ME; Ortiz, RE; Zepeda, AJ | 1 |
| Hattori, MA; He, PJ; Hirata, M; Yamauchi, N | 1 |
| Cheon, YP; Kim, CH | 1 |
| Daikoku, E; Ito, S; Kuwabara, H; Mori, H; Nakahari, T; Nakano, T; Nishimura, A; Ohmichi, M; Sakuma, K; Shimamoto, C; Ueki, M; Ushiroyama, T | 1 |
| Kang, Y; Li, G; Mao, G; Ouyang, H; Tai, P; Wang, B; Wang, J; Wen, J; Xia, G; Zou, Q | 1 |
| Choi, KC; Hyun, SH; Jeung, EB; Jung, EM; Kim, JH; Yang, H | 1 |
| Camacho-Arroyo, I; López-González, R; Velasco, I | 1 |
| Matsubara, K; Matsubara, Y | 1 |
| Guo, B; Li, DD; Li, SJ; Liu, JX; Tian, XC; Wang, ST; Yue, ZP; Zhang, XM | 1 |
| Ahn, C; An, BS; Jeung, EB; Lee, D; Yang, H | 1 |
| Dehghan, F; Muniandy, S; Salleh, N; Yusof, A | 1 |
| Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH | 1 |
| Aiso, S; Hiraoka, Y; Nogami, H | 1 |
| Ahn, C; An, BS; Jeung, EB; Kang, HY; Kim, K; Lee, D; Seong, YH | 1 |
| Cruz-Raya, U; Espinosa-Raya, J; López-Martínez, M; Picazo, O | 1 |
| Cui, S; Liu, J; Qiu, J; Yan, L; Zhang, Y | 1 |
| Jeung, EB; Jung, EM; Park, SY; Yoo, YM | 1 |
| Benyhe, S; Gáspár, R; Kothencz, A; Mirdamadi, M; Szécsi, M; Szűcs, E | 1 |
3 review(s) available for fulvestrant and mifepristone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Hormone Antagonists; Humans; Leiomyoma; Lymphokines; Mifepristone; Progestins; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Transcription, Genetic; Uterine Neoplasms; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins | 2016 |
48 other study(ies) available for fulvestrant and mifepristone
| Article | Year |
|---|---|
The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.
Topics: Animals; Chlorocebus aethiops; Female; Humans; Hypocreales; Indoles; Luciferases; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Progestins; Receptors, Progesterone; Sesquiterpenes | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Estrogenic activity of RU 486 (mifepristone) in rat uterus and cultured uterine myocytes.
Topics: Animals; Cells, Cultured; Cricetinae; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, Reporter; Mesocricetus; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Transfection; Uterus | 1995 |
Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins.
Topics: Breast Neoplasms; DNA, Neoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Tumor Cells, Cultured | 1993 |
Regulation of epidermal growth factor receptor synthesis by ovarian steroids in human endometrial cells in culture.
Topics: Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Endometrium; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Mifepristone; Progesterone; Protein Binding; Stimulation, Chemical | 1996 |
Anti-implantation activity of antiestrogens and mifepristone.
Topics: Administration, Oral; Animals; Contraceptives, Postcoital; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Injections, Subcutaneous; Male; Mifepristone; Norandrostanes; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
Effect of mifepristone and antiestrogens on uterine PGF2 alpha and PGE2 concentrations in ovariectomized and pregnant rats.
Topics: Abortifacient Agents, Steroidal; Animals; Contraceptives, Postcoital, Synthetic; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryonic Development; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Mifepristone; Norandrostanes; Organ Size; Ovariectomy; Pregnancy; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1997 |
Regulation of progesterone biosynthesis in the human placenta by estradiol 17 beta and progesterone.
Topics: Estradiol; Fadrozole; Female; Fulvestrant; Gonanes; Homeostasis; Hormone Antagonists; Humans; Mifepristone; Placenta; Pregnancy; Progesterone | 1997 |
In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Signaling; Coronary Vasospasm; Coronary Vessels; Disease Models, Animal; Disease Susceptibility; Enzyme Activation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Antagonists; Hormone Replacement Therapy; Humans; Macaca mulatta; Microscopy, Confocal; Microscopy, Fluorescence; Mifepristone; Muscle Proteins; Muscle, Smooth, Vascular; Ovariectomy; Postmenopause; Progesterone; Protein Kinase C; Receptors, Estrogen; Receptors, Progesterone; Serotonin; Thromboxane A2; Vasoconstriction | 1998 |
Antisteroidal compounds and steroid withdrawal down-regulate cadherin-11 mRNA and protein expression levels in human endometrial stromal cells undergoing decidualisation in vitro.
Topics: Cadherins; Cells, Cultured; Decidua; Down-Regulation; Endometrium; Estradiol; Female; Fulvestrant; Hormone Antagonists; Humans; In Vitro Techniques; Mifepristone; Pregnancy; Progesterone; RNA, Messenger; Steroids; Stromal Cells | 1999 |
Regulation of HOXA-10 and its expression in normal and abnormal endometrium.
Topics: Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo Implantation; Endometriosis; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Homeobox A10 Proteins; Homeodomain Proteins; Hormone Antagonists; Humans; Menstrual Cycle; Mifepristone; Progesterone; Reference Values; Relaxin; Stromal Cells | 1999 |
Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
Topics: Animals; Endothelial Growth Factors; Estradiol; Female; Fulvestrant; Gonanes; Hormone Antagonists; Lymphokines; Mifepristone; Progestins; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mifepristone; Progestins; Prostate-Specific Antigen; Proteins; Receptors, Estrogen; Receptors, Progesterone; Tissue Kallikreins; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |
Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
Topics: Animals; Cell Division; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Antagonists; Hormone Replacement Therapy; Image Processing, Computer-Assisted; Immunohistochemistry; Mammary Glands, Animal; Mice; Mice, Inbred BALB C; Mifepristone; Models, Animal; Ovariectomy; Postmenopause; Progesterone; Radionuclide Imaging; Receptors, Progesterone; Thymidine; Tritium | 2001 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogens; Fulvestrant; Gonanes; Humans; Mifepristone; Phosphorylation; Progesterone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Retinoblastoma Protein; Tumor Cells, Cultured | 2001 |
Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus.
Topics: Animals; Endothelial Growth Factors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Lymphokines; Male; Mice; Mice, Mutant Strains; Mifepristone; Neovascularization, Physiologic; Progesterone; Receptor Protein-Tyrosine Kinases; Receptors, Estrogen; Receptors, Growth Factor; Receptors, Prolactin; Receptors, Vascular Endothelial Growth Factor; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Calcitonin expression in rat anterior pituitary gland is regulated by ovarian steroid hormones.
Topics: Animals; Calcitonin; Estradiol; Estrogen Antagonists; Estrus; Female; Fulvestrant; Hormone Antagonists; Immunization, Passive; Mifepristone; Ovariectomy; Pituitary Gland, Anterior; Progesterone; Progestins; Prolactin; Rats; Rats, Inbred F344; Receptors, Calcitonin; RNA, Messenger | 2002 |
Expression and regulation of calcitonin gene-related Peptide receptor in rat placentas.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Endothelium, Vascular; Estradiol; Female; Fluorescent Antibody Technique; Fulvestrant; Gene Expression Regulation; Gestational Age; Labor, Obstetric; Mifepristone; Muscle, Smooth, Vascular; Placenta; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Calcitonin Gene-Related Peptide; Tissue Distribution; Trophoblasts | 2002 |
Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Receptor-Like Protein; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Gestational Age; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mifepristone; Placenta; Pregnancy; Progesterone; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Up-Regulation | 2003 |
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Topics: Aldosterone; Androgen Antagonists; Cell Line; Cell Line, Tumor; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; Dexamethasone; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Imidazoles; Kallikreins; Kinetics; Mifepristone; Nitriles; Norgestrel; Promoter Regions, Genetic; Recombinant Fusion Proteins; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Up-Regulation | 2003 |
Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Coloring Agents; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Fulvestrant; G1 Phase; Hormone Antagonists; Humans; Immunoblotting; Mifepristone; Phosphorylation; Receptors, Estrogen; Receptors, Progesterone; Resting Phase, Cell Cycle; Tamoxifen; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Novel progestogenic activity of environmental endocrine disruptors in the upregulation of calbindin-D9k in an immature mouse model.
Topics: Animals; Benzhydryl Compounds; Calbindins; Dose-Response Relationship, Drug; Endocrine System; Estradiol; Estrogens, Non-Steroidal; Female; Fulvestrant; Mice; Mice, Inbred Strains; Mifepristone; Models, Animal; Phenols; Progesterone; Receptors, Estrogen; Receptors, Progesterone; S100 Calcium Binding Protein G; Time Factors; Up-Regulation; Uterus | 2005 |
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis.
Topics: Animals; Apoptosis; Cell Nucleus; Cells, Cultured; Dexamethasone; Estradiol; Fulvestrant; Glucocorticoids; In Situ Nick-End Labeling; Mice; Mifepristone; Osteocytes; Receptors, Glucocorticoid | 2005 |
Non-genomic action of estradiol and progesterone on cytosolic calcium concentrations in primary cultures of human granulosa-lutein cells.
Topics: Calcium; Cells, Cultured; Cytosol; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Antagonists; Humans; Luteal Cells; Mifepristone; Progesterone | 2005 |
The effects of blocking the actions of estrogen and progesterone on the rates of proliferation and apoptosis of cervical epithelial and stromal cells during the second half of pregnancy in rats.
Topics: Animals; Apoptosis; Cell Proliferation; Cervix Uteri; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Hormone Antagonists; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Relaxin; Stromal Cells | 2005 |
Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Topics: Antibodies; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Gene Expression; Histone Acetyltransferases; Humans; Luciferases; Mammary Tumor Virus, Mouse; Mifepristone; Nuclear Receptor Coactivator 1; Phosphatidylinositol 3-Kinases; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Recombinant Fusion Proteins; Response Elements; Signal Transduction; Transcription Factors; Transfection; Vascular Endothelial Growth Factor A | 2005 |
Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Mitoxantrone; Neoplasm Proteins; Placenta; Pregnancy; Progesterone; Receptors, Progesterone | 2006 |
17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.
Topics: Cell Line; Cell Line, Tumor; Chemokines; Cytokines; Endometrium; Epithelial Cells; Estradiol; Female; Fulvestrant; Humans; Mifepristone; Poly I-C; Polydeoxyribonucleotides; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Toll-Like Receptor 3 | 2005 |
Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens.
Topics: Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; HeLa Cells; Histone Acetyltransferases; Humans; Mifepristone; Nandrolone; Nuclear Receptor Coactivator 1; Progesterone; Progestins; Protein Conformation; Receptors, Progesterone; Receptors, Steroid; Recombinant Proteins; Transcription Factors; Transfection; Trypsin | 2006 |
Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780.
Topics: Acetylcysteine; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Enzyme Inhibitors; Estradiol; Fas Ligand Protein; fas Receptor; Female; Fulvestrant; Humans; Hydrogen Peroxide; Hydroxamic Acids; Mifepristone; Norpregnadienes; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Stromal Cells | 2006 |
Progesterone, but not luteal estrogen, is required for the establishment of pregnancy in the new world monkey Cebus apella.
Topics: Animals; Aromatase Inhibitors; Cebus; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Letrozole; Luteal Phase; Male; Mifepristone; Nitriles; Pregnancy; Pregnancy Rate; Pregnancy, Animal; Progesterone; Triazoles | 2007 |
Up-regulation of Per1 expression by estradiol and progesterone in the rat uterus.
Topics: Animals; Cell Cycle Proteins; Circadian Rhythm; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Hormone Antagonists; In Situ Hybridization; Microscopy, Fluorescence; Mifepristone; Myometrium; Ovariectomy; Period Circadian Proteins; Pregnancy; Progesterone; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Uterus | 2007 |
Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.
Topics: Animals; Cell Proliferation; Endometrium; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Male; Mice; Mifepristone; Organ Specificity; Ovariectomy; Pregnancy; Progesterone; Protein Kinases; Tissue Distribution; Tumor Suppressor Proteins; Uterus | 2010 |
Ciliary beat frequency controlled by oestradiol and progesterone during ovarian cycle in guinea-pig Fallopian tube.
Topics: Animals; Cilia; Estradiol; Estrous Cycle; Fallopian Tubes; Female; Fulvestrant; Guinea Pigs; Medroxyprogesterone; Microscopy, Video; Mifepristone; Ovulation; Progesterone; Receptors, Estradiol; Receptors, Progesterone | 2010 |
Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice.
Topics: Animals; Blotting, Western; Cells, Cultured; Estradiol; Female; Fulvestrant; Lymphocyte Count; Mice; Mifepristone; Pregnancy; Progesterone; Radioimmunoassay; T-Lymphocytes, Regulatory; Uterus | 2010 |
Duodenal and renal transient receptor potential vanilloid 6 is regulated by sex steroid hormones, estrogen and progesterone, in immature rats.
Topics: Animals; Blotting, Western; Duodenum; Estradiol; Female; Fulvestrant; Hormone Antagonists; Kidney; Mifepristone; Progesterone; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TRPV Cation Channels | 2011 |
Progesterone and 17β-estradiol increase differentiation of mouse embryonic stem cells to motor neurons.
Topics: Analysis of Variance; Animals; Cell Differentiation; Choline O-Acetyltransferase; DNA Primers; Embryonic Stem Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Flow Cytometry; Fulvestrant; Immunohistochemistry; LIM-Homeodomain Proteins; Mice; Mifepristone; Motor Neurons; Progesterone; Pyrazoles; Pyrimidines; Real-Time Polymerase Chain Reaction; Transcription Factors | 2011 |
Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation.
Topics: Adult; Cell Proliferation; Endothelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Luteal Phase; Menstrual Cycle; Mifepristone; Neovascularization, Physiologic; Progesterone; Stem Cells | 2012 |
Differential expression and regulation of angiopoietin-3 in mouse uterus during preimplantation period.
Topics: Angiopoietins; Animals; Embryo Implantation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Developmental; In Situ Hybridization; Mice; Mifepristone; Neovascularization, Physiologic; Pregnancy; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Uterus | 2012 |
Placental claudin expression and its regulation by endogenous sex steroid hormones.
Topics: Animals; Claudins; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression; Gene Expression Regulation; Male; Mice, Inbred ICR; Mifepristone; Placenta; Pregnancy; Receptors, Progesterone | 2015 |
Estrogen receptor (ER)-α, β and progesterone receptor (PR) mediates changes in relaxin receptor (RXFP1 and RXFP2) expression and passive range of motion of rats' knee.
Topics: Animals; Estradiol; Female; Fulvestrant; Hindlimb; Male; Mifepristone; Piperidines; Progesterone; Pyrazoles; Pyrimidines; Range of Motion, Articular; Rats; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Receptors, Peptide; Steroids | 2015 |
Estradiol and corticosterone stimulate the proliferation of a GH cell line, MtT/S: Proliferation of growth hormone cells.
Topics: Animals; Cell Line; Cell Proliferation; Corticosterone; Estradiol; Estrogen Receptor Antagonists; Estrogens; Fulvestrant; Glucocorticoids; Growth Hormone; Hormone Antagonists; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger; Serum Albumin, Bovine; Somatotrophs; Spironolactone | 2016 |
Effects of estrogen on esophageal function through regulation of Ca
Topics: Animals; Calcium; Esophagus; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Mifepristone; Mucin-2; Mucins; Muscle Contraction; Muscle, Smooth; Plasma Membrane Calcium-Transporting ATPases; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Calcium Exchanger; Transcription, Genetic | 2017 |
Choline acetyltransferase and TrkA expression, as well as the improvement in cognition produced by E2 and P4 in ovariectomized rats, are blocked by ICI 182 780 and RU486.
Topics: Animals; Choline O-Acetyltransferase; Cognition; Estradiol; Female; Fulvestrant; Learning; Mifepristone; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Receptor, trkA | 2018 |
cGMP-dependent protein kinase II determines β-catenin accumulation that is essential for uterine decidualization in mice.
Topics: Animals; beta Catenin; Cell Proliferation; Cyclic AMP; Cyclic GMP-Dependent Protein Kinase Type II; Decidua; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Isoquinolines; Mice; Mifepristone; Ovariectomy; Phosphorylation; Pregnancy; Primary Cell Culture; Progesterone; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Stromal Cells; Sulfonamides; Uterus | 2019 |
The effect of steroid hormone on the expression of the calcium-processing proteins in the immature female rat brain.
Topics: Animals; Brain; Calcium; Calcium Channels; Dexamethasone; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Hormone Antagonists; Mifepristone; Plasma Membrane Calcium-Transporting ATPases; Progesterone; Rats; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; TRPV Cation Channels | 2020 |
Non-genomic actions of sex hormones on pregnant uterine contractility in rats: An in vitro study at term.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Female; Flutamide; Fulvestrant; Mifepristone; Muscle Contraction; Potassium Chloride; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Testosterone; Uterine Contraction | 2020 |